Nektar therapeutics (NKTR)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

227,035

96,363

81,224

85,424

106,752

194,905

222,261

911,125

34,805

4,762

37,967

16,149

23,480

59,640

63,295

55,676

72,549

55,570

18,819

20,875

129,452

12,365

32,008

30,699

32,443

39,067

65,411

41,432

28,531

25,437

10,338

136,154

148,485

15,312

43,008

11,626

22,485

17,755

Short-term investments

1,118,847

1,228,499

1,414,448

1,429,955

1,281,913

1,140,445

1,198,149

912,683

261,854

291,370

314,600

249,398

335,043

329,462

190,216

219,178

215,776

253,374

249,000

233,785

171,353

225,459

204,635

245,737

251,628

197,959

118,139

160,453

207,664

251,757

308,939

296,720

233,624

225,856

223,479

351,280

496,157

298,177

Accounts receivable

42,031

36,802

41,205

37,299

42,894

43,213

31,937

35,315

15,607

5,014

3,314

4,114

1,565

15,678

14,249

27,777

39,677

19,947

2,966

3,680

2,885

3,607

46,074

3,047

1,855

2,229

4,557

6,041

3,647

5,805

3,911

11,361

10,803

4,938

12,914

8,460

2,160

25,102

Inventory

14,320

12,665

13,720

13,188

11,778

11,381

13,296

11,884

10,675

10,726

13,654

11,008

13,016

11,109

10,754

10,262

11,250

11,346

10,352

10,124

12,511

12,952

11,695

14,111

12,872

13,452

15,076

20,479

18,381

18,269

16,754

14,715

14,108

12,656

10,654

9,797

11,712

7,266

Advance payments to contract manufacturers

13,280

31,834

13,015

17,738

27,425

26,450

26,999

-

-

7,155

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

25,000

25,000

25,000

25,000

25,000

25,000

25,000

25,000

25,000

25,000

25,000

-

-

-

-

-

-

-

-

Other current assets

13,811

15,731

15,212

13,213

19,352

21,293

12,540

34,940

13,074

7,793

13,260

7,496

7,881

10,063

4,008

5,427

5,593

9,814

5,214

8,782

6,092

8,817

4,708

4,629

5,972

5,175

4,759

6,018

8,813

13,363

7,003

9,341

13,634

17,944

7,565

7,932

6,859

5,679

Total current assets

1,429,324

1,421,894

1,578,824

1,596,817

1,490,114

1,437,687

1,505,182

1,905,947

336,015

326,820

382,795

288,165

380,985

425,952

282,522

318,320

344,845

350,051

286,351

302,246

347,293

288,200

324,120

298,223

304,770

257,882

207,942

234,423

267,036

314,631

346,945

468,291

420,654

276,706

297,620

389,095

539,373

353,979

Long-term investments

185,900

279,119

231,082

276,305

455,867

582,889

619,140

282,277

37,157

57,088

59,596

45,160

3,493

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44,245

116,732

173,768

191,478

118,941

-

-

Restricted cash and long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,022

-

-

-

-

-

-

-

Property, plant and equipment, net

62,307

65,665

64,614

65,453

58,158

48,851

44,881

45,000

46,328

47,463

62,396

64,929

66,642

65,601

65,553

67,774

69,852

71,336

72,532

72,158

69,267

70,368

69,275

71,070

72,968

66,974

65,082

67,849

70,112

72,215

73,256

73,713

75,557

78,576

81,649

85,381

87,628

89,773

Operating lease right-of-use assets

133,901

134,177

134,888

82,177

83,475

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

76,501

Other assets

-

-

2,385

2,400

2,367

4,244

3,394

3,362

789

994

767

1,104

865

817

519

504

681

754

13,862

5,762

6,151

6,552

7,006

7,343

7,774

8,170

8,510

9,036

9,252

9,443

9,728

5,693

5,345

999

845

936

976

972

Total assets

1,887,933

1,977,356

2,088,294

2,099,653

2,166,482

2,150,172

2,249,098

2,313,087

496,790

508,866

582,055

475,859

528,486

568,871

425,095

463,099

491,879

498,642

449,246

456,667

499,212

441,621

476,902

478,137

487,013

434,527

383,035

412,809

447,901

497,790

541,452

668,443

694,789

606,550

648,093

670,854

704,478

521,225

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Capital lease obligations, current portion

-

-

-

-

-

-

-

-

-

-

2,482

2,706

2,909

-

2,370

3,616

4,782

4,756

5,883

5,643

5,412

4,512

-

-

-

3,536

-

-

-

-

-

-

-

-

-

-

-

-

Liability related to refundable upfront payment

-

-

-

-

-

-

-

-

-

-

12,500

12,500

12,500

12,500

12,500

12,500

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Senior secured notes, net and interest payable

254,144

252,891

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

125,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

21,789

19,234

21,963

9,346

11,012

5,854

7,494

10,674

11,375

4,782

8,563

6,241

6,951

2,816

7,118

2,328

2,349

2,363

2,279

2,833

5,024

2,703

5,428

7,437

3,064

9,115

3,723

5,572

4,218

2,863

2,624

3,118

1,761

3,019

2,175

3,243

3,481

7,194

Accrued compensation

22,412

11,467

23,101

19,710

18,371

9,937

27,922

18,980

15,130

8,263

19,088

14,346

11,463

18,280

15,733

12,463

10,044

5,998

12,805

10,824

9,356

5,749

13,753

11,386

9,427

14,254

13,910

11,087

8,952

8,773

12,687

10,519

8,187

12,807

11,760

9,435

7,680

9,252

Accrued clinical trial expenses

38,624

32,626

38,338

29,540

17,496

14,700

21,966

20,028

19,790

9,461

7,000

6,683

7,443

7,958

10,946

13,470

10,596

8,220

11,102

8,946

8,747

7,708

9,643

13,208

13,726

16,905

15,239

16,935

24,032

17,500

13,200

12,607

12,726

11,953

13,612

13,832

13,649

12,144

Accrued contract manufacturing expenses

8,579

7,304

8,646

23,159

21,384

23,841

-

-

-

3,845

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued expenses

11,844

11,414

11,394

13,830

14,624

9,087

24,217

14,993

10,676

6,219

9,302

6,683

6,576

4,711

6,761

6,919

6,284

4,156

16,561

9,713

8,245

6,418

7,760

5,814

6,821

6,243

10,771

11,356

6,946

8,008

6,450

7,636

7,759

6,669

11,777

8,129

9,231

8,540

Interest payable

-

-

4,198

4,144

4,090

4,198

4,198

4,144

4,090

4,198

4,198

4,144

4,090

4,198

4,198

4,144

4,144

4,198

3,167

6,917

3,167

6,917

3,167

6,917

3,167

6,917

3,167

6,917

3,167

7,083

-

-

-

1,805

-

-

-

-

Operating lease liabilities, current portion

15,613

12,516

9,318

3,749

1,649

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, current portion

3,007

5,517

8,400

9,900

11,092

13,892

15,676

17,988

19,531

18,949

25,491

13,373

24,192

14,352

14,101

16,015

17,240

21,428

20,611

22,987

24,959

24,473

24,626

24,766

23,542

23,664

21,300

22,113

23,239

21,896

22,639

20,691

20,007

19,643

19,982

19,867

19,974

20,584

Liability related to the sale of future royalties, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,000

-

-

-

3,000

-

-

-

-

-

-

-

-

Convertible subordinated notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

214,955

214,955

214,955

214,955

-

-

-

Other current liabilities

1,459

1,692

-

-

-

493

6,610

10,090

105

446

3,920

5,937

2,391

7,407

2,578

7,827

10,506

10,127

10,690

13,214

10,534

5,567

16,172

14,827

19,566

10,587

12,803

16,297

12,667

9,414

11,870

7,335

5,358

4,681

4,781

6,768

4,865

6,394

Total current liabilities

377,471

354,661

125,350

113,370

99,718

82,002

108,083

96,897

80,697

56,163

92,544

72,613

78,515

72,222

76,305

79,282

65,945

61,246

208,098

81,077

75,444

64,047

80,549

84,355

79,313

98,221

80,913

90,277

83,221

78,537

69,470

276,861

270,753

275,532

279,042

61,274

58,880

64,108

Senior secured notes, net

-

-

248,257

247,821

247,386

246,950

246,514

246,078

245,643

245,207

244,771

244,336

243,900

243,464

243,004

242,567

242,130

241,699

0

125,000

125,000

125,000

125,000

125,000

125,000

125,000

125,000

125,000

125,000

125,000

125,000

-

-

-

-

-

-

-

Operating lease liabilities, less current portion

142,297

142,730

145,099

94,822

95,024

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible subordinated notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

214,955

214,955

214,955

Capital lease obligations, less current portion

-

-

-

-

-

-

-

-

-

-

-

1,056

1,609

-

2,143

2,756

3,325

1,073

1,335

2,889

4,386

4,139

5,339

6,025

7,050

8,049

9,007

9,901

10,766

11,607

12,414

13,174

13,890

14,582

15,250

15,863

16,448

17,014

Liability related to the sale of future royalties, net

69,185

72,020

73,455

77,813

80,837

82,911

85,402

88,867

92,846

94,655

98,394

101,897

103,931

105,950

108,893

111,590

114,631

116,029

121,147

121,971

121,558

120,471

120,492

121,431

121,134

121,520

125,167

124,074

122,416

128,266

126,746

127,686

125,785

0

-

-

-

-

Deferred revenue, less current portion

2,554

2,554

6,800

8,000

9,340

10,744

11,410

13,780

12,808

19,021

56,225

48,979

51,666

51,887

57,088

60,135

59,587

62,426

68,941

73,963

78,418

76,911

82,902

88,918

76,549

82,384

82,233

93,516

97,918

96,551

101,762

108,215

111,050

108,188

113,045

117,931

122,818

124,763

Liability related to receipt of refundable milestone payment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70,000

70,000

70,000

-

-

-

-

-

-

-

-

-

-

-

-

Deferred gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,748

1,967

2,185

-

-

-

-

3,278

3,497

3,715

3,934

4,152

Other long-term liabilities

-

-

643

643

666

9,990

7,567

7,051

6,513

5,992

5,959

3,592

4,116

7,223

5,515

6,020

6,536

9,740

10,672

16,668

17,101

14,721

15,402

17,768

17,776

19,256

9,217

8,623

9,015

10,811

10,728

10,223

10,824

7,159

6,462

5,840

6,205

5,571

Total liabilities

591,507

571,965

599,583

542,498

532,971

432,597

458,976

452,673

438,507

421,038

497,893

472,473

483,737

480,746

492,948

502,350

492,154

492,213

410,193

421,568

421,907

405,289

429,684

513,497

496,822

524,430

433,285

453,358

450,521

450,772

446,120

536,159

532,302

408,739

417,296

419,578

423,240

430,563

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized; no shares designated or outstanding at March 31, 2020 or December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value; 300,000 shares authorized; 177,863 shares and 176,505 shares outstanding at March 31, 2020 and December 31, 2019, respectively

17

17

17

17

17

17

17

17

16

15

15

15

15

15

13

13

13

13

13

13

13

13

12

12

12

11

11

11

11

11

11

11

11

11

11

11

11

9

Capital in excess of par value

3,306,655

3,271,097

3,241,160

3,210,398

3,178,773

3,147,925

3,121,322

3,094,095

2,262,219

2,207,865

2,170,169

2,150,019

2,131,698

2,111,483

1,912,907

1,898,342

1,888,531

1,876,072

1,854,210

1,841,730

1,831,057

1,824,195

1,789,010

1,776,746

1,769,713

1,643,660

1,636,162

1,628,967

1,623,207

1,617,744

1,612,620

1,606,800

1,602,141

1,597,428

1,592,803

1,587,461

1,580,990

1,354,232

Accumulated other comprehensive loss

-6,877

-1,005

-1,186

-788

-2,716

-6,316

-5,378

-4,002

-2,796

-2,111

-1,907

-1,662

-1,849

-2,363

-1,962

-2,019

-1,835

-2,170

-1,821

-1,498

-1,276

-1,567

-1,178

-887

-940

-1,181

-1,689

-1,336

-395

-357

155

-620

-43

-1,103

-987

766

818

968

Accumulated deficit

-2,003,369

-1,864,718

-1,751,280

-1,652,472

-1,542,563

-1,424,051

-1,325,839

-1,229,696

-2,201,156

-2,117,941

-2,084,115

-2,144,986

-2,085,115

-2,021,010

-1,978,811

-1,935,587

-1,886,984

-1,867,486

-1,813,349

-1,805,146

-1,752,489

-1,786,309

-1,740,626

-1,811,231

-1,778,594

-1,732,393

-1,684,734

-1,668,191

-1,625,443

-1,570,380

-1,517,454

-1,473,907

-1,439,622

-1,398,525

-1,361,030

-1,336,962

-1,300,581

-1,264,547

Total stockholders’ equity

1,296,426

1,405,391

1,488,711

1,557,155

1,633,511

1,717,575

1,790,122

1,860,414

58,283

87,828

84,162

3,386

44,749

88,125

-67,853

-39,251

-275

6,429

39,053

35,099

77,305

36,332

47,218

-35,360

-9,809

-89,903

-50,250

-40,549

-2,620

47,018

95,332

132,284

162,487

197,811

230,797

251,276

281,238

90,662

Total liabilities and stockholders’ equity

1,887,933

1,977,356

2,088,294

2,099,653

2,166,482

2,150,172

2,249,098

2,313,087

496,790

508,866

582,055

475,859

528,486

568,871

425,095

463,099

491,879

498,642

449,246

456,667

499,212

441,621

476,902

478,137

487,013

434,527

383,035

412,809

447,901

497,790

541,452

668,443

694,789

606,550

648,093

670,854

704,478

521,225